Antibe Therapeutics Inc (OTCMKTS:ATBPF) Stock Extends Rally: Soars 22% in a Week

In the past week the Antibe Therapeutics Inc (OTCMKTS:ATBPF) stock has been in focus among investors and the trend continued to hold on Tuesday. Yesterday, the stock jumped again and ended with gains of 5%. That took its gains over the course of the past week to as much as 22%.

The company is involved in the deployment of its sulphide platform for the purposes of creating new age therapies which are safe enough to treat a variety of inflammatory conditions. Yesterday, Antibe announced that it was going to be one of the participants at the Canaccord Genuity 41st Annual Growth Conference.

The event in question is going be held virtually from August 10 up until August 12. The Chief Medical Officer of Antibe, Dr. Joseph Stauffer and the company’s Chief Executive Officer Dan Legault are going to be making the presentations.

The presentation in question is going to be made at 9 p.m. Eastern Time on August 12. Investors could do well to keep an eye on what the two executives say at their presentation since it could have a direct bearing on the Antibe stock. Interested parties could take a look at the presentation through a webcast on the company’s website.

Related Posts

About The Author